The MICs and minimal lethal concentrations of four antimycotics, amphotericin B, 5-fluorocytosine, miconazole nitrate, and ketoconazole, were determined for 25 yeast isolates representing species uncommonly implicated in candidiasis. A microdilution procedure was employed with complex and synthetic media. The isolates, in general, were susceptible to the same antimicrobial agents shown to be effective against Candida albicans, but differences between some of the species in relative susceptibilities to the antifungal agents were noted. Isolates of atypical sucrose-negative Candida tropicalis were similar in their susceptibility patterns to typical isolates of the species. Relative resistance to amphotericin B, miconazole nitrate, and ketoconazole was noted for two Candida lusitaniae isolates, but all strains were susceptible to 5-fluorocytosine. Candida norvegensis isolates were more resistant to miconazole and ketoconazole than C. albicans clinical isolates. The microtiter system was satisfactory for determining minimal inhibitory concentrations, but the system is not recommended for detecting finite differences in drug susceptibilities or for detecting drug synergism. 
The MICs and minimal lethal concentrations of four antimycotics, amphotericin B, 5-fluorocytosine, miconazole nitrate, and ketoconazole, were determined for 25 yeast isolates representing species uncommonly implicated in candidiasis. A microdilution procedure was employed with complex and synthetic media. The isolates, in general, were susceptible to the same antimicrobial agents shown to be effective against Candida albicans, but differences between some of the species in relative susceptibilities to the antifungal agents were noted. Isolates of atypical sucrose-negative Candida tropicalis were similar in their susceptibility patterns to typical isolates of the species. Relative resistance to amphotericin B, miconazole nitrate, and ketoconazole was noted for two Candida lusitaniae isolates, but all strains were susceptible to 5-fluorocytosine. Candida norvegensis isolates were more resistant to miconazole and ketoconazole than C. albicans clinical isolates. The microtiter system was satisfactory for determining minimal inhibitory concentrations, but the system is not recommended for detecting finite differences in drug susceptibilities or for detecting drug synergism.
Most studies on the in vitro antimycotic susceptibilities of clinical yeasts have been performed with Candida albicans or typical Candida tropicalis isolates (7, 16) . Ahearn et al. (1) described a sucrose-negative (sn) variant of C. tropicalis from three cases of systemic candidiasis. Subsequently, this variant and a phenotypically similar yeast, Candida lusitaniae, have been reported in clinical specimens from diverse sites in the United States (2, 6, 10) . Little or no information is available on the drug susceptibilities of these yeasts. The purpose of this investigation is twofold: (i) to Synergistic activity by microtiter assay. Possible synergy between KTZ and rifampin was examined with a constant subinhibitory concentration of rifampin (10 ,ug/ml) and with increasing concentrations of KTZ. A KTZ working solution of 100 ,ug/ml was serially diluted in SAAMF as described above. After the wells were inoculated, 50 of SAAMF was added to increase the volume to 0.1 ml per well. Finally, 0.1 ml of SAAMF containing rifampin (20 ,ug/ml) was added for a final volume of 0.2 ml per well. The concentration of KTZ theoretically ranged from 6.25 to 0.01125 ,ug/ml. All tests were performed in duplicate and incubated in the dark at room temperature for 72 h. Synergy was designated as a twofold decrease in MICs when the two drugs were combined as compared with either drug alone.
RESULTS
The relative susceptibilities of the yeasts to AMB, 5-FC, MCZ, and KTZ are given in Table 2 . For the most part, the fungicidal antimicrobial AMB gave MLCs only slightly higher than the MICs. Only the seven C. lusitaniae isolates had MLCs to AMB that were more than two dilutions greater than their MICs. In contrast, MLCs for the static antimicrobial agents, 5-FC, MCZ, and KTZ, exceeded the MICs by at least two dilutions for most yeasts. The C. tropicalis (sn) strains appeared more susceptible to AMB than to the other antimicrobial agents (Fig. 1) (3) .
No evidence of synergistic activity between KTZ and rifampin for C. norvegensis was obtained with the microtiter assay. This species was chosen for synergy study since it included the only isolates somewhat resistant to KTZ in SAAMF. The control strain of C. albicans (Ca3O) also gave no evidence of a synergistic effect of the two drugs. However, the MIC of KTZ for the control strain was reduced by one dilution in the presence of rifampin as determined by a standard tube dilution procedure. Lack of synergistic inhibition of Candida spp. with combinations of rifampin and KTZ has been reported previously (7) . DISCUSSION The C. tropicalis (sn) were similar in their in vitro susceptibilities (with selected antifungals) to typical isolates of the species and to values reported for C. albicans (11) . Resistance to 5-FC is common among candidas, and it was observed for several of the C. tropicalis (sn) isolates. MICs to MCZ and KTZ in YNB indicated in vitro resistance to the imidazoles among both typical and atypical C. tropicalis. These data were in accord with MICs reported by Moody et al. (7) for C. tropicalis isolates tested by an agar dilution procedure.
In contrast to results obtained with YNB and SAB, the MICs to MCZ and KTZ for all yeasts determined in SAAMF were within achievable serum levels. Hoeprich and Huston (5) reported similar findings with SAAMF and suggested that MCZ and possibly other imidazoles are blocked from full expression of activity in more complex media but not in synthetic media.
Van den Bossche et al. (15) reported that the effects of MCZ appear pronounced in logarithmically growing cells, which suggests high metabolic activity enhances susceptibility to the drug. In this regard, the SAB used by Moody et al. (7) probably contained sterols or sterol precursors that antagonized the activity of the imidazoles and produced high MICs. As contrasted with SAAMF, we observed relatively high MICs with the imidazoles in YNB medium, although this defined medium is supposedly also free of sterols. YNB and SAAMF supported equivalent growth of most yeasts, but the MICs for MCZ and KTZ at 48 h were higher for most yeasts in YNB as compared with SAAMF; however, 24-h data appeared similar.
The two C. lusitaniae strains (numbers 19 and 20) were the only strains which gave MICs to AMB that exceeded attain- .09
.045 (6, 9) . Both resistant isolates were previously reported to have MICs of 30 ,ug/ml for AMB at 24 h by a YNB agar dilution procedure (9) . In our study, the two isolates were relatively resistant compared with other isolates examined on M-20 (MICs of 6.3 pg/ml). As noted above, YNB and SAAMF are synthetic media without sterols and other complex macromolecules that could interfere with AMB activity. Therefore, the resistant values for these strains in YNB reported by Pappagianis et al. (9) argue against sterol antagonism as an explanation for differences in MICs in M-20 and SAAMF for these particular isolates. The results seem to indicate a uniqueness of these strains, since the concentrations of sterols in M-20 were apparently insufficient to antagonize the AMB activity with all other isolates whose MICs in SAAMF were essentially the same as their MICs in M-20. In support of this supposition is the observation that the same two C. lusitaniae isolates were relatively resistant to MCZ and KTZ in YNB compared with the other isolates of this species. The relation of the unique results with these strains to a membrane phenomenon may be supported by the findings that inhibition by imidazoles has been related to an effect on steroid metabolism (14, 15) . In other studies, the effects of KTZ on C. albicans have included selective inhibition of the mycelial phase (13) and inhibition of the respiration of logarithmic phase cells (12) . The inhibitory effects of the imidazoles on yeasts appear to be strongly affected by conditions for their growth.
Since the development of in vivo polyene and imidazole resistance among some C. lusitaniae strains is possible, 5-FC may be the drug of choice for therapy. The MICs to 5-FC for all C. lusitaniae isolates were very low, and their MLCs were all -1.6 jig/ml. Apparently, 5-FC has a fungicidal effect with this species rather than a fungistatic effect. Furthermore, no evidence of resistance to 5-FC was noted in the assay tests.
Among those clinical isolates resistant to 5-FC were the two C. norvegensis isolates. This species is only occasionally isolated from clinical specimens, and it has not been established as an agent of adventitious infections. Unlike all other isolates, the susceptibilities to imidazoles for both C. norvegensis isolates were essentially the same in both YNB and SAAMF.
SAAMF appeared to provide optimal activity for most antifungals. Hoeprich and Huston (5) recommended SAAMF because of its lack of antagonism to antifungals, its nutritional adequacy for a wide variety of fungi, the superior stability of pH, and the certifiable absence of macromolecules, chelators, purines, pyrimidines, and sterols. However, they did observe that YNB appears to be optimal for testing 5-FC. This observation was supported by our results; MICs of 5-FC in YNB were generally lower than those seen with SAAMF.
The benefits of a microtiter system for screening antimicrobial susceptibilities of yeasts include savings in space, media, and time in handling large numbers of isolates. The actual incubation time, however, may need to be extended over that of a macro system for certain Candida strains. We found that the microtiter system provides relatively accurate MIC data but required somewhat more care in interpretation. We do not recommend our microtiter system for detecting finite differences in drug susceptibilities or for detecting drug synergism.
